Surgery Partners (NASDAQ:SGRY) Director Teresa Deluca Sells 20,018 Shares

Key Points

• Surgery Partners, Inc. Director Teresa Deluca sold 20,018 shares of the company's stock for a total of $455,209.32, reducing her ownership by 30.71% and leaving her with 45,173 shares valued at over $1 million.
• The company recently reported a positive earnings surprise with $0.17 earnings per share, surpassing the consensus estimate of $0.16, alongside a revenue of $826.20 million for the quarter.
• Surgery Partners has attracted attention from analysts, with ratings ranging from "hold" to "buy", and a consensus price target set at $33.00 as research firms adjust their price objectives.

Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) Director Teresa Deluca sold 20,018 shares of the firm's stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $22.74, for a total transaction of $455,209.32. Following the completion of the transaction, the director directly owned 45,173 shares in the company, valued at approximately $1,027,234.02. This represents a 30.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Surgery Partners Price Performance

NASDAQ SGRY traded up $0.7550 during trading hours on Tuesday, hitting $23.2450. 611,786 shares of the company's stock traded hands, compared to its average volume of 1,407,649. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.93 and a quick ratio of 1.78. The firm's 50-day moving average is $22.11 and its 200-day moving average is $22.93. Surgery Partners, Inc. has a 52-week low of $18.87 and a 52-week high of $33.97. The company has a market capitalization of $2.98 billion, a PE ratio of -16.26 and a beta of 1.82.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.17 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.01. Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%.The business had revenue of $826.20 million for the quarter, compared to analysts' expectations of $816.96 million. During the same period in the previous year, the firm posted $0.21 EPS. The business's revenue for the quarter was up 8.4% compared to the same quarter last year. Equities analysts forecast that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

Analyst Ratings Changes

SGRY has been the topic of several recent analyst reports. Benchmark reiterated a "buy" rating and issued a $35.00 target price on shares of Surgery Partners in a report on Monday, April 21st. Barclays decreased their price objective on Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 27th. Finally, Bank of America started coverage on Surgery Partners in a research report on Monday, July 28th. They issued a "buy" rating and a $28.00 target price on the stock. Six equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat, Surgery Partners presently has a consensus rating of "Moderate Buy" and a consensus price target of $33.00.

Institutional Trading of Surgery Partners

Institutional investors and hedge funds have recently bought and sold shares of the business. LPL Financial LLC increased its stake in Surgery Partners by 22.4% during the 4th quarter. LPL Financial LLC now owns 16,749 shares of the company's stock worth $355,000 after buying an additional 3,062 shares during the period. Wells Fargo & Company MN increased its position in shares of Surgery Partners by 1.4% during the fourth quarter. Wells Fargo & Company MN now owns 56,931 shares of the company's stock worth $1,205,000 after acquiring an additional 783 shares during the period. Envestnet Asset Management Inc. raised its stake in shares of Surgery Partners by 17.9% in the fourth quarter. Envestnet Asset Management Inc. now owns 32,707 shares of the company's stock valued at $692,000 after acquiring an additional 4,954 shares in the last quarter. Barclays PLC boosted its holdings in Surgery Partners by 9.3% in the fourth quarter. Barclays PLC now owns 141,094 shares of the company's stock valued at $2,987,000 after purchasing an additional 11,961 shares during the period. Finally, Dimensional Fund Advisors LP grew its stake in Surgery Partners by 18.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,577,861 shares of the company's stock worth $75,739,000 after purchasing an additional 563,812 shares in the last quarter.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.